title: Editorial: therapeutic de-escalation of anti-tumour necrosis factor therapy - is less enough?
authors.affiliation: Division of Gastroenterology, Center for Inflammatory Bowel Diseases, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
authors.forename: K
authors.identifier: 0000-0003-1497-0254
authors.initials: K
authors.lastname: Papamichael
authors.affiliation: Division of Gastroenterology, Center for Inflammatory Bowel Diseases, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
authors.forename: A S
authors.initials: AS
authors.lastname: Cheifetz
mesh_terms: D000068879:Adalimumab; D006801:Humans; D000069285:Infliximab; D048069:Tumor Necrosis Factors
chemical_list: D048069:Tumor Necrosis Factors; D000069285:Infliximab; D000068879:Adalimumab